文章基本信息

标题：Edoxaban in venous thromboembolism and stroke prevention: an appraisal
本地全文：下载
作者：Marco Proietti ; Gregory YH Lip
期刊名称：Vascular Health and Risk Management
印刷版ISSN：1176-6344
电子版ISSN：1178-2048
出版年度：2016
卷号：12
页码：45-51
DOI：10.2147/VHRM.S81569
出版社：Dove Medical Press Ltd
摘要：Oral anticoagulation is the therapeutic cornerstone in preventing thromboembolic risk in both atrial fibrillation (AF) and venous thromboembolism (VTE). After decades of the sole therapeutic oral anticoagulation option being warfarin, the introduction of non-vitamin K antagonist oral anticoagulants has heralded a new era. Edoxaban is the latest addition to these available for clinical use. Edoxaban was as effective and safer than warfarin in preventing thromboembolic risk in AF patients. Similarly, edoxaban effectiveness and safety was evident when treating VTE patients to prevent recurrent VTE or VTE-related death. Therefore, edoxaban represents a valuable alternative in treating thromboembolic risk for AF and VTE patients.
关键词：atrial fibrillation; venous thromboembolism; stroke; anticoagulation; edoxaban